Amalgamated Bank purchased a new stake in NutriSystem Inc. (NASDAQ:NTRI) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 4,696 shares of the company’s stock, valued at approximately $206,000.
Other hedge funds have also recently made changes to their positions in the company. Csenge Advisory Group acquired a new position in NutriSystem in the 3rd quarter worth $28,000. Meeder Asset Management Inc. boosted its stake in NutriSystem by 139.5% in the 4th quarter. Meeder Asset Management Inc. now owns 733 shares of the company’s stock worth $31,000 after purchasing an additional 427 shares during the period. FNY Investment Advisers LLC acquired a new position in NutriSystem in the 4th quarter worth $36,000. Doyle Wealth Management acquired a new position in NutriSystem in the 4th quarter worth $75,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in NutriSystem by 34.1% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,935 shares of the company’s stock worth $85,000 after purchasing an additional 492 shares during the period.
Shares of NASDAQ NTRI opened at $42.89 on Wednesday. The firm has a market capitalization of $1.26 billion, a P/E ratio of 20.33, a P/E/G ratio of 1.52 and a beta of 0.48. NutriSystem Inc. has a 1-year low of $26.06 and a 1-year high of $45.25.
A number of equities analysts recently weighed in on the stock. Zacks Investment Research lowered shares of NutriSystem from a “hold” rating to a “sell” rating in a research note on Saturday, February 23rd. BidaskClub lowered shares of NutriSystem from a “hold” rating to a “sell” rating in a research note on Saturday, January 19th. Finally, ValuEngine raised shares of NutriSystem from a “hold” rating to a “buy” rating in a research note on Friday, December 21st. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $43.71.
NutriSystem Company Profile
Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a D' kit that offers individuals with or at risk of type 2 diabetes.
See Also: What is the balance sheet?
Want to see what other hedge funds are holding NTRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NutriSystem Inc. (NASDAQ:NTRI).
Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.